Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does RABEPRAZOLE Cause Therapeutic product effect incomplete? 151 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 151 reports of Therapeutic product effect incomplete have been filed in association with RABEPRAZOLE (Rabeprazole Sodium). This represents 1.3% of all adverse event reports for RABEPRAZOLE.

151
Reports of Therapeutic product effect incomplete with RABEPRAZOLE
1.3%
of all RABEPRAZOLE reports
0
Deaths
45
Hospitalizations

How Dangerous Is Therapeutic product effect incomplete From RABEPRAZOLE?

Of the 151 reports, 45 (29.8%) required hospitalization.

Is Therapeutic product effect incomplete Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for RABEPRAZOLE. However, 151 reports have been filed with the FAERS database.

What Other Side Effects Does RABEPRAZOLE Cause?

Chronic kidney disease (4,773) Renal failure (3,135) Acute kidney injury (2,545) End stage renal disease (1,295) Tubulointerstitial nephritis (1,125) Death (857) Drug ineffective (732) Dyspnoea (423) Gastrooesophageal reflux disease (416) Headache (387)

What Other Drugs Cause Therapeutic product effect incomplete?

ALBUTEROL (8,496) ADALIMUMAB (6,986) PREDNISONE (6,709) METHOTREXATE (6,037) TOFACITINIB (4,914) SECUKINUMAB (4,661) BUDESONIDE\FORMOTEROL (4,392) TIOTROPIUM (4,327) MEPOLIZUMAB (4,106) ETANERCEPT (3,961)

Which RABEPRAZOLE Alternatives Have Lower Therapeutic product effect incomplete Risk?

RABEPRAZOLE vs RACECADOTRIL RABEPRAZOLE vs RADIATION THERAPY RABEPRAZOLE vs RADIUM RA-223 DICHLORIDE RABEPRAZOLE vs RALOXIFENE RABEPRAZOLE vs RALTEGRAVIR

Related Pages

RABEPRAZOLE Full Profile All Therapeutic product effect incomplete Reports All Drugs Causing Therapeutic product effect incomplete RABEPRAZOLE Demographics